{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28503571", "DateCompleted": {"Year": "2018", "Month": "02", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "04", "Day": "19"}], "Language": ["eng"], "ELocationID": ["6596241", "10.1155/2017/6596241"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2017", "PubDate": {"Year": "2017"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression.", "Pagination": {"StartPage": "6596241", "MedlinePgn": "6596241"}, "Abstract": {"AbstractText": ["<i>Background</i>. Depression is a recurrent, common, and potentially life-threatening psychiatric disease related to multiple assignable causes. Although conventional antidepressant therapy can help relieve symptoms of depression and prevent relapse of the illness, complementary therapies are required due to disadvantage of the current therapy such as adverse effects. Moreover, a number of studies have researched adjunctive therapeutic approaches to improve outcomes for depression patients. <i>Purpose</i>. One potential complementary method with conventional antidepressants involves the use of medicinal herbs and phytochemicals that provide therapeutic benefits. Studies have revealed beneficial effects of medical herbs and phytochemicals on depression and their central nervous system mechanism. Here, we summarize the current knowledge of the therapeutic benefits of phytochemicals and medicinal herbs against depression and describe their detailed mechanisms. <i>Sections</i>. There are two sections, phytochemicals against depression and medical herbs against depression, in this review. <i>Conclusion</i>. Use of phytomedicine may be an alternative option for the treatment of depression in case conventional drugs are not applicable due to their side effects, low effectiveness, or inaccessibility. However, the efficacy and safety of these phytomedicine treatments for depression have to be supported by clinical studies."]}, "AuthorList": [{"Identifier": ["0000-0001-6250-8852"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, College of Korean Medicine, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 02447, Republic of Korea."}, {"Identifier": [], "Affiliation": "Department of Research and Development, National Development Institute of Korean Medicine, 94 Hwarang-ro, Gyeongsan-si, Gyeongsangbuk-do 38540, Republic of Korea."}], "LastName": "Lee", "ForeName": "Gihyun", "Initials": "G"}, {"Identifier": ["0000-0002-0299-3582"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, College of Korean Medicine, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 02447, Republic of Korea."}], "LastName": "Bae", "ForeName": "Hyunsu", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nemeroff C. B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. Journal of Psychiatric Research. 2007;41(3-4):189\u2013206. doi: 10.1016/j.jpsychires.2006.05.008.", "ArticleIdList": ["10.1016/j.jpsychires.2006.05.008", "16870212"]}, {"Citation": "Stewart W. F. S., Ricci J. A., Chee E., Hahn S. R., Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135\u20133144. doi: 10.1001/jama.289.23.3135.", "ArticleIdList": ["10.1001/jama.289.23.3135", "12813119"]}, {"Citation": "Berton O., Nestler E. J. New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews Neuroscience. 2006;7(2):137\u2013151. doi: 10.1038/nrn1846.", "ArticleIdList": ["10.1038/nrn1846", "16429123"]}, {"Citation": "Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33(1):73\u201383. doi: 10.1038/sj.npp.1301571.", "ArticleIdList": ["10.1038/sj.npp.1301571", "17882234"]}, {"Citation": "Mitchelmore C., Gede L. Brain derived neurotrophic factor: epigenetic regulation in psychiatric disorders. Brain Research. 2014;1586:162\u2013172. doi: 10.1016/j.brainres.2014.06.037.", "ArticleIdList": ["10.1016/j.brainres.2014.06.037", "25223903"]}, {"Citation": "Rot M. A. H., Mathew S. J., Charney D. S. Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal. 2009;180(3):305\u2013313. doi: 10.1503/cmaj.080697.", "ArticleIdList": ["10.1503/cmaj.080697", "PMC2630359", "19188629"]}, {"Citation": "Shulman K. I., Herrmann N., Walker S. E. Current place of monoamine oxidase inhibitors in the treatment of depression. CNS Drugs. 2013;27(10):789\u2013797. doi: 10.1007/s40263-013-0097-3.", "ArticleIdList": ["10.1007/s40263-013-0097-3", "23934742"]}, {"Citation": "Gillman P. K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology. 2007;151(6):737\u2013748. doi: 10.1038/sj.bjp.0707253.", "ArticleIdList": ["10.1038/sj.bjp.0707253", "PMC2014120", "17471183"]}, {"Citation": "Nemeroff C. B. Prevalence and management of treatment-resistant depression. Journal of Clinical Psychiatry. 2007;68, supplement 8:17\u201325. doi: 10.4088/jcp.0707e17.", "ArticleIdList": ["10.4088/jcp.0707e17", "17640154"]}, {"Citation": "Trivedi M. H., Fava M., Wisniewski S. R., et al. Medication augmentation after the failure of SSRIs for depression. The New England Journal of Medicine. 2006;354(12):1243\u20131252. doi: 10.1056/nejmoa052964.", "ArticleIdList": ["10.1056/nejmoa052964", "16554526"]}, {"Citation": "Baker C. B., Johnsrud M. T., Crismon M. L., Rosenheck R. A., Woods S. W. Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry. 2003;183:498\u2013506. doi: 10.1192/bjp.183.6.498.", "ArticleIdList": ["10.1192/bjp.183.6.498", "14645020"]}, {"Citation": "Meijer W. E. E., Heerdink E. R., Nolen W. A., Herings R. M. C., Leufkens H. G. M., Egberts A. C. G. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Archives of Internal Medicine. 2004;164(21):2367\u20132370. doi: 10.1001/archinte.164.21.2367.", "ArticleIdList": ["10.1001/archinte.164.21.2367", "15557417"]}, {"Citation": "Linde K. St. John's wort\u2014an overview. Forschende Komplementarmedizin. 2009;16(3):146\u2013155. doi: 10.1159/000209290.", "ArticleIdList": ["10.1159/000209290", "19657198"]}, {"Citation": "Khawam E. A., Laurencic G., Malone D. A., Jr. Side effects of antidepressants: an overview. Cleveland Clinic Journal of Medicine. 2006;73(4):351\u2013361. doi: 10.3949/ccjm.73.4.351.", "ArticleIdList": ["10.3949/ccjm.73.4.351", "16610395"]}, {"Citation": "Friedman M. Chemistry and multibeneficial bioactivities of carvacrol (4-isopropyl-2-methylphenol), a component of essential oils produced by aromatic plants and spices. Journal of Agricultural and Food Chemistry. 2014;62(31):7652\u20137670. doi: 10.1021/jf5023862.", "ArticleIdList": ["10.1021/jf5023862", "25058878"]}, {"Citation": "Xu H., Delling M., Jun J. C., Clapham D. E. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nature Neuroscience. 2006;9(5):628\u2013635. doi: 10.1038/nn1692.", "ArticleIdList": ["10.1038/nn1692", "16617338"]}, {"Citation": "Hotta M., Nakata R., Katsukawa M., Hori K., Takahashi S., Inoue H. Carvacrol, a component of thyme oil, activates PPAR\u03b1 and \u03b3 and suppresses COX-2 expression. Journal of Lipid Research. 2010;51(1):132\u2013139. doi: 10.1194/jlr.M900255-JLR200.", "ArticleIdList": ["10.1194/jlr.M900255-JLR200", "PMC2789773", "19578162"]}, {"Citation": "Dong R.-H., Fang Z.-Z. E., Zhu L.-L., et al. Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs) Pharmazie. 2012;67(12):1002\u20131006. doi: 10.1691/ph.2012.2534.", "ArticleIdList": ["10.1691/ph.2012.2534", "23346763"]}, {"Citation": "Melo F. H. C., Moura B. A., de Sousa D. P., et al. Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system. Fundamental and Clinical Pharmacology. 2011;25(3):362\u2013367. doi: 10.1111/j.1472-8206.2010.00850.x.", "ArticleIdList": ["10.1111/j.1472-8206.2010.00850.x", "20608992"]}, {"Citation": "Zotti M., Colaianna M., Morgese M. G., et al. Carvacrol: from ancient flavoring to neuromodulatory agent. Molecules. 2013;18(6):6161\u20136172. doi: 10.3390/molecules18066161.", "ArticleIdList": ["10.3390/molecules18066161", "PMC6270539", "23708230"]}, {"Citation": "Wilken R., Veena M. S., Wang M. B., Srivatsan E. S. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer. 2011;10, article 12 doi: 10.1186/1476-4598-10-12.", "ArticleIdList": ["10.1186/1476-4598-10-12", "PMC3055228", "21299897"]}, {"Citation": "Devassy J. G., Nwachukwu I. D., Jones P. J. H. Curcumin and cancer: barriers to obtaining a health claim. Nutrition Reviews. 2015;73(3):155\u2013165. doi: 10.1093/nutrit/nuu064.", "ArticleIdList": ["10.1093/nutrit/nuu064", "26024538"]}, {"Citation": "Yallapu M. M., Jaggi M., Chauhan S. C. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discovery Today. 2012;17(1-2):71\u201380. doi: 10.1016/j.drudis.2011.09.009.", "ArticleIdList": ["10.1016/j.drudis.2011.09.009", "PMC3259195", "21959306"]}, {"Citation": "Xu Y., Ku B.-S., Yao H.-Y., et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology Biochemistry and Behavior. 2005;82(1):200\u2013206. doi: 10.1016/j.pbb.2005.08.009.", "ArticleIdList": ["10.1016/j.pbb.2005.08.009", "16171853"]}, {"Citation": "Kulkarni S. K., Bhutani M. K., Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology. 2008;201(3):435\u2013442. doi: 10.1007/s00213-008-1300-y.", "ArticleIdList": ["10.1007/s00213-008-1300-y", "18766332"]}, {"Citation": "Bhutani M. K., Bishnoi M., Kulkarni S. K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacology Biochemistry and Behavior. 2009;92(1):39\u201343. doi: 10.1016/j.pbb.2008.10.007.", "ArticleIdList": ["10.1016/j.pbb.2008.10.007", "19000708"]}, {"Citation": "Wang R., Xu Y., Wu H.-L., et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European Journal of Pharmacology. 2008;578(1):43\u201350. doi: 10.1016/j.ejphar.2007.08.045.", "ArticleIdList": ["10.1016/j.ejphar.2007.08.045", "17942093"]}, {"Citation": "Xu Y., Ku B., Cui L., et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research. 2007;1162(1):9\u201318. doi: 10.1016/j.brainres.2007.05.071.", "ArticleIdList": ["10.1016/j.brainres.2007.05.071", "17617388"]}, {"Citation": "Hurley L. L., Akinfiresoye L., Nwulia E., Kamiya A., Kulkarni A. A., Tizabi Y. Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behavioural Brain Research. 2013;239(1):27\u201330. doi: 10.1016/j.bbr.2012.10.049.", "ArticleIdList": ["10.1016/j.bbr.2012.10.049", "PMC3525727", "23142609"]}, {"Citation": "Srinivasan M., Sudheer A. R., Menon V. P. Ferulic acid: therapeutic potential through its antioxidant property. Journal of Clinical Biochemistry and Nutrition. 2007;40(2):92\u2013100. doi: 10.3164/jcbn.40.92.", "ArticleIdList": ["10.3164/jcbn.40.92", "PMC2127228", "18188410"]}, {"Citation": "Kawabata K., Yamamoto T., Hara A., et al. Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Letters. 2000;157(1):15\u201321. doi: 10.1016/S0304-3835(00)00461-4.", "ArticleIdList": ["10.1016/S0304-3835(00)00461-4", "10893437"]}, {"Citation": "Balasubashini M. S., Rukkumani R., Viswanathan P., Menon V. P. Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytotherapy Research. 2004;18(4):310\u2013314. doi: 10.1002/ptr.1440.", "ArticleIdList": ["10.1002/ptr.1440", "15162367"]}, {"Citation": "Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V., Butterfield D. A. Ferulic acid ethyl ester protects neurons against amyloid \u03b2-peptide(1\u201342)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. Journal of Neurochemistry. 2005;92(4):749\u2013758. doi: 10.1111/j.1471-4159.2004.02899.x.", "ArticleIdList": ["10.1111/j.1471-4159.2004.02899.x", "15686476"]}, {"Citation": "Yogeeta S. K., Hanumantra R. B. R., Gnanapragasam A., Senthilkumar S., Subhashini R., Devaki T. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Basic and Clinical Pharmacology and Toxicology. 2006;98(5):467\u2013472. doi: 10.1111/j.1742-7843.2006.pto_335.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_335.x", "16635105"]}, {"Citation": "Yabe T., Hirahara H., Harada N., et al. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience. 2010;165(2):515\u2013524. doi: 10.1016/j.neuroscience.2009.10.023.", "ArticleIdList": ["10.1016/j.neuroscience.2009.10.023", "19837139"]}, {"Citation": "Mu W., Zhang T., Jiang B. An overview of biological production of L-theanine. Biotechnology Advances. 2015;33(3-4):335\u2013342. doi: 10.1016/j.biotechadv.2015.04.004.", "ArticleIdList": ["10.1016/j.biotechadv.2015.04.004", "25871834"]}, {"Citation": "Nathan P. J., Lu K., Gray M., Oliver C. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. Journal of Herbal Pharmacotherapy. 2006;6(2):21\u201330. doi: 10.1300/j157v06n02_02.", "ArticleIdList": ["10.1300/j157v06n02_02", "17182482"]}, {"Citation": "Kakuda T., Nozawa A., Sugimoto A., Niino H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors. Bioscience, Biotechnology and Biochemistry. 2002;66(12):2683\u20132686. doi: 10.1271/bbb.66.2683.", "ArticleIdList": ["10.1271/bbb.66.2683", "12596867"]}, {"Citation": "Lu K., Gray M. A., Oliver C., et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Human Psychopharmacology. 2004;19(7):457\u2013465. doi: 10.1002/hup.611.", "ArticleIdList": ["10.1002/hup.611", "15378679"]}, {"Citation": "Gomez-Ramirez M., Kelly S. P., Montesi J. L., Foxe J. J. The effects of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task. Brain Topography. 2009;22(1):44\u201351. doi: 10.1007/s10548-008-0068-z.", "ArticleIdList": ["10.1007/s10548-008-0068-z", "18841456"]}, {"Citation": "Yin C., Gou L., Liu Y., et al. Antidepressant-like effects of L-theanine in the forced swim and tail suspension tests in mice. Phytotherapy Research. 2011;25(11):1636\u20131639. doi: 10.1002/ptr.3456.", "ArticleIdList": ["10.1002/ptr.3456", "21425373"]}, {"Citation": "Hidese S., Ota M., Wakabayashi C., et al. Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiatrica. 2017;29(2):72\u201379. doi: 10.1017/neu.2016.33.", "ArticleIdList": ["10.1017/neu.2016.33", "27396868"]}, {"Citation": "Preuss H. G., Wallerstedt D., Talpur N., et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. Journal of Medicine. 2000;31(5-6):227\u2013246.", "ArticleIdList": ["11508317"]}, {"Citation": "Uchida S., Hirai K., Hatanaka J., Hanato J., Umegaki K., Yamada S. Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biological and Pharmaceutical Bulletin. 2008;31(2):240\u2013245. doi: 10.1248/bpb.31.240.", "ArticleIdList": ["10.1248/bpb.31.240", "18239280"]}, {"Citation": "Sato M., Bagchi D., Tosaki A., Das D. K. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radical Biology and Medicine. 2001;31(6):729\u2013737. doi: 10.1016/S0891-5849(01)00626-8.", "ArticleIdList": ["10.1016/S0891-5849(01)00626-8", "11557310"]}, {"Citation": "Xu Y., Li S., Chen R., et al. Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system. Pharmacology Biochemistry and Behavior. 2010;94(3):447\u2013453. doi: 10.1016/j.pbb.2009.10.007.", "ArticleIdList": ["10.1016/j.pbb.2009.10.007", "19857512"]}, {"Citation": "Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Letters. 2008;269(2):315\u2013325. doi: 10.1016/j.canlet.2008.03.046.", "ArticleIdList": ["10.1016/j.canlet.2008.03.046", "18467024"]}, {"Citation": "Russo G. L., Russo M., Spagnuolo C., et al. Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treatment and Research. 2014;159:185\u2013205. doi: 10.1007/978-3-642-38007-5_11.", "ArticleIdList": ["10.1007/978-3-642-38007-5_11", "24114481"]}, {"Citation": "Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones. 2007;6(3):173\u2013193.", "ArticleIdList": ["17724002"]}, {"Citation": "Bhutada P., Mundhada Y., Bansod K., et al. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010;34(6):955\u2013960. doi: 10.1016/j.pnpbp.2010.04.025.", "ArticleIdList": ["10.1016/j.pnpbp.2010.04.025", "20447436"]}, {"Citation": "Turner R. S., Thomas R. G., Craft S., et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85(16):1383\u20131391. doi: 10.1212/WNL.0000000000002035.", "ArticleIdList": ["10.1212/WNL.0000000000002035", "PMC4626244", "26362286"]}, {"Citation": "Walle T., Hsieh F., DeLegge M. H., Oatis J. E., Jr., Walle U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition. 2004;32(12):1377\u20131382. doi: 10.1124/dmd.104.000885.", "ArticleIdList": ["10.1124/dmd.104.000885", "15333514"]}, {"Citation": "Asensi M., Medina I., Ortega A., et al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology and Medicine. 2002;33(3):387\u2013398. doi: 10.1016/S0891-5849(02)00911-5.", "ArticleIdList": ["10.1016/S0891-5849(02)00911-5", "12126761"]}, {"Citation": "Tredici G., Miloso M., Nicolini G., Galbiati S., Cavaletti G., Bertelli A. Resveratrol, MAP kinases and neuronal cells: might wine be a neuroprotectant? Drugs under Experimental and Clinical Research. 1999;25(2-3):99\u2013103.", "ArticleIdList": ["10370870"]}, {"Citation": "Feng Y., Cui Y., Gao J. L., et al. Neuroprotective effects of resveratrol against traumatic brain injury in rats: involvement of synaptic proteins and neuronal autophagy. Molecular Medicine Reports. 2016;13(6):5248\u20135254. doi: 10.3892/mmr.2016.5201.", "ArticleIdList": ["10.3892/mmr.2016.5201", "27122047"]}, {"Citation": "Kumar A., Naidu P. S., Seghal N., Padi S. S. V. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology. 2007;79(1):17\u201326. doi: 10.1159/000097511.", "ArticleIdList": ["10.1159/000097511", "17135773"]}, {"Citation": "Ranney A., Petro M. S. Resveratrol protects spatial learning in middle-aged C57BL/6 mice from effects of ethanol. Behavioural Pharmacology. 2009;20(4):330\u2013336. doi: 10.1097/FBP.0b013e32832f0193.", "ArticleIdList": ["10.1097/FBP.0b013e32832f0193", "19571741"]}, {"Citation": "Y\u00e1\u00f1ez M., Fraiz N., Cano E., Orallo F. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochemical and Biophysical Research Communications. 2006;344(2):688\u2013695. doi: 10.1016/j.bbrc.2006.03.190.", "ArticleIdList": ["10.1016/j.bbrc.2006.03.190", "16631124"]}, {"Citation": "Xu Y., Wang Z., You W., et al. Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. European Neuropsychopharmacology. 2010;20(6):405\u2013413. doi: 10.1016/j.euroneuro.2010.02.013.", "ArticleIdList": ["10.1016/j.euroneuro.2010.02.013", "20353885"]}, {"Citation": "Yu Y., Wang R., Chen C., et al. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. Journal of Psychiatric Research. 2013;47(3):315\u2013322. doi: 10.1016/j.jpsychires.2012.10.018.", "ArticleIdList": ["10.1016/j.jpsychires.2012.10.018", "23174668"]}, {"Citation": "Ernst E., White A. The BBC survey of complementary medicine use in the UK. Complementary Therapies in Medicine. 2000;8(1):32\u201336. doi: 10.1054/ctim.2000.0341.", "ArticleIdList": ["10.1054/ctim.2000.0341", "10812758"]}, {"Citation": "Eisenberg D. M., Davis R. B., Ettner S. L., et al. Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey. Journal of the American Medical Association. 1998;280(18):1569\u20131575. doi: 10.1001/jama.280.18.1569.", "ArticleIdList": ["10.1001/jama.280.18.1569", "9820257"]}, {"Citation": "Tait E. M., Laditka S. B., Laditka J. N., Nies M. A., Racine E. F. Use of complementary and alternative medicine for physical performance, energy, immune function, and general health among older women and men in the United States. Journal of Women and Aging. 2012;24(1):23\u201343. doi: 10.1080/08952841.2012.638875.", "ArticleIdList": ["10.1080/08952841.2012.638875", "22256876"]}, {"Citation": "Kales H. C., Blow F. C., Welsh D. E., Mellow A. M. Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers. Journal of Geriatric Psychiatry and Neurology. 2004;17(1):25\u201331. doi: 10.1177/0891988703261998.", "ArticleIdList": ["10.1177/0891988703261998", "15018694"]}, {"Citation": "Roy-Byrne P. P., Bystritsky A., Russo J., Craske M. G., Sherbourne C. D., Stein M. B. Use of herbal medicine in primary care patients with mood and anxiety disorders. Psychosomatics. 2005;46(2):117\u2013122. doi: 10.1176/appi.psy.46.2.117.", "ArticleIdList": ["10.1176/appi.psy.46.2.117", "15774949"]}, {"Citation": "Silvers K. M., Woolley C. C., Hedderley D. Dietary supplement use in people being treated for depression. Asia Pacific Journal of Clinical Nutrition. 2006;15(1):30\u201334.", "ArticleIdList": ["16500875"]}, {"Citation": "Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytotherapy Research. 2006;20(12):1023\u20131035. doi: 10.1002/ptr.1970.", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Sarris J. Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytotherapy Research. 2007;21(8):703\u2013716. doi: 10.1002/ptr.2187.", "ArticleIdList": ["10.1002/ptr.2187", "17562566"]}, {"Citation": "Afzal M., Safer A. M., Menon M. Green tea polyphenols and their potential role in health and disease. Inflammopharmacology. 2015;23(4):151\u2013161. doi: 10.1007/s10787-015-0236-1.", "ArticleIdList": ["10.1007/s10787-015-0236-1", "26164000"]}, {"Citation": "Zhu W.-L., Shi H.-S., Wei Y.-M., et al. Green tea polyphenols produce antidepressant-like effects in adult mice. Pharmacological Research. 2012;65(1):74\u201380. doi: 10.1016/j.phrs.2011.09.007.", "ArticleIdList": ["10.1016/j.phrs.2011.09.007", "21964320"]}, {"Citation": "Moshiri E., Basti A. A., Noorbala A.-A., Jamshidi A.-H., Hesameddin Abbasi S., Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006;13(9-10):607\u2013611. doi: 10.1016/j.phymed.2006.08.006.", "ArticleIdList": ["10.1016/j.phymed.2006.08.006", "16979327"]}, {"Citation": "Akhondzadeh S., Tahmacebi-Pour N., Noorbala A.-A., et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytotherapy Research. 2005;19(2):148\u2013151. doi: 10.1002/ptr.1647.", "ArticleIdList": ["10.1002/ptr.1647", "15852492"]}, {"Citation": "Akhondzadeh Basti A., Moshiri E., Noorbala A.-A., Jamshidi A.-H., Abbasi S. H., Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007;31(2):439\u2013442. doi: 10.1016/j.pnpbp.2006.11.010.", "ArticleIdList": ["10.1016/j.pnpbp.2006.11.010", "17174460"]}, {"Citation": "Akhondzadeh S., Fallah-Pour H., Afkham K., Jamshidi A.-H., Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816] BMC Complementary and Alternative Medicine. 2004;4, article 12 doi: 10.1186/1472-6882-4-12.", "ArticleIdList": ["10.1186/1472-6882-4-12", "PMC517724", "15341662"]}, {"Citation": "Noorbala A. A., Akhondzadeh S., Tahmacebi-Pour N., Jamshidi A. H. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology. 2005;97(2):281\u2013284. doi: 10.1016/j.jep.2004.11.004.", "ArticleIdList": ["10.1016/j.jep.2004.11.004", "15707766"]}, {"Citation": "Hausenblas H. A., Saha D., Dubyak P. J., Anton S. D. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine. 2013;11(6):377\u2013383. doi: 10.3736/jintegrmed2013056.", "ArticleIdList": ["10.3736/jintegrmed2013056", "PMC4643654", "24299602"]}, {"Citation": "Lopresti A. L., Drummond P. D. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology. 2014;29(6):517\u2013527. doi: 10.1002/hup.2434.", "ArticleIdList": ["10.1002/hup.2434", "25384672"]}, {"Citation": "Mazidi M., Shemshian M., Mousavi S. H., et al. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. Journal of Complementary and Integrative Medicine. 2016;13(2):195\u2013199. doi: 10.1515/jcim-2015-0043.", "ArticleIdList": ["10.1515/jcim-2015-0043", "27101556"]}, {"Citation": "Abolhassani M. Antiviral activity of borage (Echium amoenum) Archives of Medical Science. 2010;6(3):366\u2013369. doi: 10.5114/aoms.2010.14256.", "ArticleIdList": ["10.5114/aoms.2010.14256", "PMC3282513", "22371772"]}, {"Citation": "Sayyah M., Sayyah M., Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006;30(1):166\u2013169. doi: 10.1016/j.pnpbp.2005.10.005.", "ArticleIdList": ["10.1016/j.pnpbp.2005.10.005", "16309809"]}, {"Citation": "Kasper S., Volz H. P., M\u00f6ller H. J., Dienel A., Kieser M. Continuation and long-term maintenance treatment with Hypericum extract WS\u00ae 5570 after recovery from an acute episode of moderate depression\u2014a double-blind, randomized, placebo controlled long-term trial. European Neuropsychopharmacology. 2008;18(11):803\u2013813. doi: 10.1016/j.euroneuro.2008.06.006.", "ArticleIdList": ["10.1016/j.euroneuro.2008.06.006", "18694635"]}, {"Citation": "Sarris J., Kavanagh D. J., Byrne G., Bone K. M., Adams J., Deed G. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology. 2009;205(3):399\u2013407. doi: 10.1007/s00213-009-1549-9.", "ArticleIdList": ["10.1007/s00213-009-1549-9", "19430766"]}, {"Citation": "Chen Q. G., Zeng Y. S., Qu Z. Q., et al. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine. 2009;16(9):830\u2013838. doi: 10.1016/j.phymed.2009.03.011.", "ArticleIdList": ["10.1016/j.phymed.2009.03.011", "19403286"]}, {"Citation": "Mattioli L., Funari C., Perfumi M. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. Journal of Psychopharmacology. 2009;23(2):130\u2013142. doi: 10.1177/0269881108089872.", "ArticleIdList": ["10.1177/0269881108089872", "18515456"]}, {"Citation": "Darbinyan V., Aslanyan G., Amroyan E., Gabrielyan E., Malmstr\u00f6m C., Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic Journal of Psychiatry. 2007;61(5):343\u2013348. doi: 10.1080/08039480701643290.", "ArticleIdList": ["10.1080/08039480701643290", "17990195"]}, {"Citation": "Hritcu L., Cioanca O., Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine. 2012;19(6):529\u2013534. doi: 10.1016/j.phymed.2012.02.002.", "ArticleIdList": ["10.1016/j.phymed.2012.02.002", "22402245"]}, {"Citation": "Effati-Daryani F., Mohammad-Alizadeh-Charandabi S., Mirghafourvand M., Taghizadeh M., Mohammadi A. Effect of lavender cream with or without foot-bath on anxiety, stress and depression in pregnancy: a randomized placebo-controlled trial. Journal of Caring Sciences. 2015;4(1):63\u201373.", "ArticleIdList": ["PMC4363653", "25821760"]}, {"Citation": "Nikfarjam M., Parvin N., Assarzadegan N., Asghari S. The effects of lavandula angustifolia mill infusion on depression in patients using citalopram: a comparison study. Iranian Red Crescent Medical Journal. 2013;15(8):734\u2013739. doi: 10.5812/ircmj.4173.", "ArticleIdList": ["10.5812/ircmj.4173", "PMC3918201", "24578844"]}, {"Citation": "Conrad P., Adams C. The effects of clinical aromatherapy for anxiety and depression in the high risk postpartum woman\u2014a pilot study. Complementary Therapies in Clinical Practice. 2012;18(3):164\u2013168. doi: 10.1016/j.ctcp.2012.05.002.", "ArticleIdList": ["10.1016/j.ctcp.2012.05.002", "22789792"]}, {"Citation": "Lee I.-S., Lee G.-J. Effects of lavender aromatherapy on insomnia and depression in women college students. Taehan Kanho Hakhoe Chi. 2006;36(1):136\u2013143.", "ArticleIdList": ["16520572"]}, {"Citation": "Akhondzadeh S., Kashani L., Fotouhi A., et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2003;27(1):123\u2013127. doi: 10.1016/s0278-5846(02)00342-1.", "ArticleIdList": ["10.1016/s0278-5846(02)00342-1", "12551734"]}, {"Citation": "Jang C.-G., Kang M., Cho J.-H., et al. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Archives of Pharmacal Research. 2004;27(10):1065\u20131072. doi: 10.1007/bf02975433.", "ArticleIdList": ["10.1007/bf02975433", "27518390"]}, {"Citation": "Kang M., Shin D., Oh J.-W., et al. The anti-depressant effect of Nelumbinis Semen on rats under chronic mild stress induced depression-like symptoms. American Journal of Chinese Medicine. 2005;33(2):205\u2013213. doi: 10.1142/S0192415X05002874.", "ArticleIdList": ["10.1142/S0192415X05002874", "15974480"]}, {"Citation": "Chung H.-S., Lee H. J., Shim I., Bae H. Assessment of anti-depressant effect of nelumbinis semen on rats under chronic mild stress and its subchronic oral toxicity in rats and beagle dogs. BMC Complementary and Alternative Medicine. 2012;12, article 68 doi: 10.1186/1472-6882-12-68.", "ArticleIdList": ["10.1186/1472-6882-12-68", "PMC3407502", "22640371"]}, {"Citation": "Butterweck V. Mechanism of action of St John's wort in depression\u2014what is known? CNS Drugs. 2003;17(8):539\u2013562. doi: 10.2165/00023210-200317080-00001.", "ArticleIdList": ["10.2165/00023210-200317080-00001", "12775192"]}, {"Citation": "Harrer G., Sommer H. Treatment of mild/moderate depressions with Hypericum. Phytomedicine. 1994;1(1):3\u20138. doi: 10.1016/S0944-7113(11)80016-4.", "ArticleIdList": ["10.1016/S0944-7113(11)80016-4", "23195809"]}, {"Citation": "Kasper S., Anghelescu I.-G., Szegedi A., Dienel A., Kieser M. Superior efficacy of St John's wort extract WS\u00ae5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298] BMC Medicine. 2006;4, article 14 doi: 10.1186/1741-7015-4-14.", "ArticleIdList": ["10.1186/1741-7015-4-14", "PMC1538611", "16796730"]}, {"Citation": "Vorbach E. U., Arnoldt K. H., Hubner W.-D. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 1997;30:81\u201385. doi: 10.1055/s-2007-979524.", "ArticleIdList": ["10.1055/s-2007-979524", "9342765"]}, {"Citation": "Philipp M., Kohnen R., Hiller K.-O. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. British Medical Journal. 1999;319(7224):1534\u20131538. doi: 10.1136/bmj.319.7224.1534.", "ArticleIdList": ["10.1136/bmj.319.7224.1534", "PMC28296", "10591711"]}, {"Citation": "Woelk H. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. British Medical Journal. 2000;321(7260):536\u2013539. doi: 10.1136/bmj.321.7260.536.", "ArticleIdList": ["10.1136/bmj.321.7260.536", "PMC27467", "10968813"]}, {"Citation": "Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. International Clinical Psychopharmacology. 2000;15(2):61\u201368. doi: 10.1097/00004850-200015020-00001.", "ArticleIdList": ["10.1097/00004850-200015020-00001", "10759336"]}, {"Citation": "Wheatley D. Ll 160, an extract of St. John's Wort, versus amitriptyline in mildly to moderately depressed outpatients\u2014a controlled 6-week clinical trial. Pharmacopsychiatry. 1997;30(2):77\u201380. doi: 10.1055/s-2007-979523.", "ArticleIdList": ["10.1055/s-2007-979523", "9342764"]}, {"Citation": "Volz H.-P., Laux P. Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine. Comprehensive Psychiatry. 2000;41(2):133\u2013137. doi: 10.1016/s0010-440x(00)80019-x.", "ArticleIdList": ["10.1016/s0010-440x(00)80019-x", "10746915"]}, {"Citation": "Vorbach E.-U., Hubner W.-D., Arnold K.-H. Effectiveness and tolerance of the hypericum extract Li-160 in comparison with imipramine\u2014Randomized double-blind-study with 135 out-patients. Nervenheilkunde. 1993;12(6):290\u2013296.", "ArticleIdList": ["7857502"]}, {"Citation": "Harrer G., Schmidt U., Kuhn U., Biller A. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine. Drug Research. 1999;49(4):289\u2013296.", "ArticleIdList": ["10337446"]}, {"Citation": "Mannel M., Kuhn U., Schmidt U., Ploch M., Murck H. St. John's wort extract LI160 for the treatment of depression with atypical features\u2014a double-blind, randomized, and placebo-controlled trial. Journal of Psychiatric Research. 2010;44(12):760\u2013767. doi: 10.1016/j.jpsychires.2010.01.010.", "ArticleIdList": ["10.1016/j.jpsychires.2010.01.010", "20181361"]}, {"Citation": "Linde K., Berner M. M., Kriston L. St John's wort for major depression. Cochrane Database of Systematic Reviews. 2009;(4)CD000448", "ArticleIdList": ["PMC7032678", "18843608"]}, {"Citation": "Rahimi R., Nikfar S., Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009;33(1):118\u2013127. doi: 10.1016/j.pnpbp.2008.10.018.", "ArticleIdList": ["10.1016/j.pnpbp.2008.10.018", "19028540"]}, {"Citation": "R\u00f6der C., Schaefer M., Leucht S. Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort. Fortschritte der Neurologie Psychiatrie. 2004;72(6):330\u2013343. doi: 10.1055/s-2003-812513.", "ArticleIdList": ["10.1055/s-2003-812513", "15211398"]}, {"Citation": "Kasper S., Caraci F., Forti B., Drago F., Aguglia E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. European Neuropsychopharmacology. 2010;20(11):747\u2013765. doi: 10.1016/j.euroneuro.2010.07.005.", "ArticleIdList": ["10.1016/j.euroneuro.2010.07.005", "20708905"]}, {"Citation": "Davidson J. R. T., Gadde K. M., Fairbank J. A., et al. Effect of Hypericum perforatum (St John's wort) in major depressive disorder\u2014a randomized controlled trial. The Journal of the American Medical Association. 2002;287(14):1807\u20131814. doi: 10.1001/jama.287.14.1807.", "ArticleIdList": ["10.1001/jama.287.14.1807", "11939866"]}, {"Citation": "Shelton R. C., Keller M. B., Gelenberg A., et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. Journal of the American Medical Association. 2001;285(15):1978\u20131986. doi: 10.1001/jama.285.15.1978.", "ArticleIdList": ["10.1001/jama.285.15.1978", "11308434"]}, {"Citation": "Borrelli F., Izzo A. A. Herb-drug interactions with St John's Wort (hypericum perforatum): an update on clinical observations. AAPS Journal. 2009;11(4):710\u2013727. doi: 10.1208/s12248-009-9146-8.", "ArticleIdList": ["10.1208/s12248-009-9146-8", "PMC2782080", "19859815"]}, {"Citation": "Markowitz J. S., Donovan J. L., DeVane C. L., et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. The Journal of the American Medical Association. 2003;290(11):1500\u20131504. doi: 10.1001/jama.290.11.1500.", "ArticleIdList": ["10.1001/jama.290.11.1500", "13129991"]}, {"Citation": "Mills E., Montori V. M., Wu P., Gallicano K., Clarke M., Guyatt G. Interaction of St John's wort with conventional drugs: systematic review of clinical trials. British Medical Journal. 2004;329(7456):27\u201330. doi: 10.1136/bmj.329.7456.27.", "ArticleIdList": ["10.1136/bmj.329.7456.27", "PMC443448", "15231618"]}, {"Citation": "Izzo A. A., Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777\u20131798. doi: 10.2165/11317010-000000000-00000.", "ArticleIdList": ["10.2165/11317010-000000000-00000", "19719333"]}, {"Citation": "Teschke R., Gaus W., Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine. 2003;10(5):440\u2013446. doi: 10.1078/0944-7113-00314.", "ArticleIdList": ["10.1078/0944-7113-00314", "12834011"]}, {"Citation": "Pantano F., Tittarelli R., Mannocchi G., et al. Hepatotoxicity induced by \u201cthe 3Ks\u201d: Kava, kratom and khat. International Journal of Molecular Sciences. 2016;17(4, article 580) doi: 10.3390/ijms17040580.", "ArticleIdList": ["10.3390/ijms17040580", "PMC4849036", "27092496"]}, {"Citation": "Hung S. K., Perry R., Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine. 2011;18(4):235\u2013244. doi: 10.1016/j.phymed.2010.08.014.", "ArticleIdList": ["10.1016/j.phymed.2010.08.014", "21036578"]}, {"Citation": "van Diermen D., Marston A., Bravo J., Reist M., Carrupt P.-A., Hostettmann K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. Journal of Ethnopharmacology. 2009;122(2):397\u2013401. doi: 10.1016/j.jep.2009.01.007.", "ArticleIdList": ["10.1016/j.jep.2009.01.007", "19168123"]}, {"Citation": "Cavanagh H. M. A., Wilkinson J. M. Biological activities of lavender essential oil. Phytotherapy Research. 2002;16(4):301\u2013308. doi: 10.1002/ptr.1103.", "ArticleIdList": ["10.1002/ptr.1103", "12112282"]}, {"Citation": "Hancianu M., Cioanca O., Mihasan M., Hritcu L. Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats. Phytomedicine. 2013;20(5):446\u2013452. doi: 10.1016/j.phymed.2012.12.005.", "ArticleIdList": ["10.1016/j.phymed.2012.12.005", "23351960"]}, {"Citation": "Kasper S., Gastpar M., M\u00fcller W. E., et al. Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder\u2014evidence from clinical trials. Wiener Medizinische Wochenschrift. 2010;160(21-22):547\u2013556. doi: 10.1007/s10354-010-0845-7.", "ArticleIdList": ["10.1007/s10354-010-0845-7", "21170695"]}, {"Citation": "Kasper S. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review. International Journal of Psychiatry in Clinical Practice. 2013;17(supplement 1):15\u201322. doi: 10.3109/13651501.2013.813555.", "ArticleIdList": ["10.3109/13651501.2013.813555", "23808618"]}, {"Citation": "Kasper S., Anghelescu I., Dienel A. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep\u2014a randomized, placebo-controlled trial. European Neuropsychopharmacology. 2015;25(11):1960\u20131967. doi: 10.1016/j.euroneuro.2015.07.024.", "ArticleIdList": ["10.1016/j.euroneuro.2015.07.024", "26293583"]}, {"Citation": "Tsai H.-H., Lin H.-W., Simon Pickard A., Tsai H.-Y., Mahady G. B. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice. 2012;66(11):1056\u20131078. doi: 10.1111/j.1742-1241.2012.03008.x.", "ArticleIdList": ["10.1111/j.1742-1241.2012.03008.x", "23067030"]}]}], "History": [{"Year": "2016", "Month": "12", "Day": "14"}, {"Year": "2017", "Month": "3", "Day": "22"}, {"Year": "2017", "Month": "4", "Day": "4"}, {"Year": "2017", "Month": "5", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28503571", "PMC5414506", "10.1155/2017/6596241"]}}]}